Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.57% | $270.93M | €475.49B | 77.75% | 76 Outperform | |
| Roche Holding AG | 2.09% | $158.67M | CHF294.84B | 43.28% | 73 Outperform | |
| AstraZeneca | 1.99% | $151.19M | $323.92B | 30.34% | 80 Outperform | |
| Novartis AG | 1.95% | $147.72M | CHF242.43B | 30.05% | 80 Outperform | |
| HSBC Holdings | 1.87% | $141.68M | £222.90B | 47.29% | 80 Outperform | |
| Nestlé SA | 1.68% | $127.53M | CHF198.29B | 7.70% | 71 Outperform | |
| Shell (UK) | 1.44% | $109.32M | £165.51B | 12.59% | 73 Outperform | |
| Siemens | 1.34% | $101.43M | €191.01B | 8.40% | 74 Outperform | |
| SAP SE | 1.28% | $97.17M | €197.41B | -38.83% | 66 Neutral | |
| Banco Santander | 1.19% | $90.09M | €157.30B | 95.13% | 73 Outperform |